Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aroamas appears to be an active private consumer health brand focused on over-the-counter smoking-cessation products and scar-care products. Publicly visible products include nicotine transdermal patches marketed for smoking cessation and silicone-based scar gels and scar sheets sold under the Aroamas Scar name. The business does not appear to be a biotech drug developer with a traditional R&D pipeline; instead, it is best characterized as a commercial-stage healthcare products company/brand. Available evidence suggests the company sells mainly through its own product websites and online marketplaces, with at least some nicotine patch labeling tied to Ehy Holdings LLC as packager/distributor. Because company-disclosed corporate information is sparse, several corporate attributes remain uncertain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aroamas.